EU is to buy Covid-19 vaccines from Spain's Hipra Human Health

The number of Covid infections in Europe is rising and “we have to make sure we are fully prepared as the autumn and winter months are approaching,” said Health Commissioner Stella Kyriakides.

This vaccine is currently undergoing evaluation by the European Medications Agency, so when it receives authorisation for sale the participating countries will be able to purchase it via this contract.

The EU has previously signed similar contracts with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica, BioNtech-Pfizer, Moderna, Novavax and Valneva, which has secured about 4.2 billion doses for the EU market as part of its coronavirus vaccination strategy.

The participating countries will have the right to decide whether to donate the vaccines to countries with low or medium incomes, or redirect them to other European countries.